ArticleCancer biotherapy & radiopharmaceuticals2012

Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.

Qing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.